These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 12052668)

  • 1. Cardiotoxicity of new antihistamines and cisapride.
    Paakkari I
    Toxicol Lett; 2002 Feb; 127(1-3):279-84. PubMed ID: 12052668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative analysis of the cardiotoxicity proclivities of second generation antihistamines in an experimental model predictive of adverse clinical ECG effects.
    Hey JA; del Prado M; Sherwood J; Kreutner W; Egan RW
    Arzneimittelforschung; 1996 Feb; 46(2):153-8. PubMed ID: 8720304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the potential cardiotoxicity of the antihistamines terfenadine, astemizole, loratadine, and cetirizine in atopic children.
    Delgado LF; Pferferman A; Solé D; Naspitz CK
    Ann Allergy Asthma Immunol; 1998 Apr; 80(4):333-7. PubMed ID: 9564984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of second generation histamine antagonists on the heart].
    Grzelewska-Rzymowska I; Pietrzkowicz M; Górska M
    Pneumonol Alergol Pol; 2001; 69(3-4):217-26. PubMed ID: 11575008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risks of non-sedating antihistamines.
    Lindquist M; Edwards IR
    Lancet; 1997 May; 349(9061):1322. PubMed ID: 9142080
    [No Abstract]   [Full Text] [Related]  

  • 6. Variations among non-sedating antihistamines: are there real differences?
    Mattila MJ; Paakkari I
    Eur J Clin Pharmacol; 1999 Apr; 55(2):85-93. PubMed ID: 10335901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second-generation antihistamines: the risk of ventricular arrhythmias.
    DuBuske LM
    Clin Ther; 1999 Feb; 21(2):281-95. PubMed ID: 10211532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of ventricular arrhythmias associated with nonsedating antihistamine drugs.
    de Abajo FJ; Rodríguez LA
    Br J Clin Pharmacol; 1999 Mar; 47(3):307-13. PubMed ID: 10215756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical in vitro cardiac electrophysiology: a method of predicting arrhythmogenic potential of antihistamines in humans?
    Cavero I; Mestre M; Guillon JM; Heuillet E; Roach AG
    Drug Saf; 1999; 21 Suppl 1():19-31; discussion 81-7. PubMed ID: 10597865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac actions of antihistamines.
    Woosley RL
    Annu Rev Pharmacol Toxicol; 1996; 36():233-52. PubMed ID: 8725389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiotoxicity of second-generation antihistamines.
    Roberts DJ
    Drugs; 1999 Jun; 57(6):1033-4. PubMed ID: 10400411
    [No Abstract]   [Full Text] [Related]  

  • 12. Antihistamine effects on actual driving performance in a standard test: a summary of Dutch experience, 1989-94.
    O'Hanlon JF; Ramaekers JG
    Allergy; 1995 Mar; 50(3):234-42. PubMed ID: 7677241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Terfenadine, astemizole, and ebastine produce QTc interval prolongation in an experimental model predictive of adverse clinical ECG effects.
    Hey JA; del Prado M; Egan RW; Kreutner W
    Ann Allergy Asthma Immunol; 1996 May; 76(5):476. PubMed ID: 8630724
    [No Abstract]   [Full Text] [Related]  

  • 14. Cardiotoxic and drug interaction profile of the second generation antihistamines ebastine and terfenadine in an experimental animal model of torsade de pointes.
    Hey JA; del Prado M; Kreutner W; Egan RW
    Arzneimittelforschung; 1996 Feb; 46(2):159-63. PubMed ID: 8720305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic overview of oral second-generation H1 antihistamines.
    González MA; Estes KS
    Int J Clin Pharmacol Ther; 1998 May; 36(5):292-300. PubMed ID: 9629995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of antihistamines in children.
    Ten Eick AP; Blumer JL; Reed MD
    Drug Saf; 2001; 24(2):119-47. PubMed ID: 11235817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular toxicity of antihistamines.
    Smith SJ
    Otolaryngol Head Neck Surg; 1994 Sep; 111(3 Pt 2):348-54. PubMed ID: 7916150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. H1-receptor antagonists: safety issues.
    Estelle F; Simons R
    Ann Allergy Asthma Immunol; 1999 Nov; 83(5):481-8. PubMed ID: 10582735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac safety of second-generation H
    Cataldi M; Maurer M; Taglialatela M; Church MK
    Clin Exp Allergy; 2019 Dec; 49(12):1615-1623. PubMed ID: 31519068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dangers of non-sedating antihistamines.
    Clark S
    Lancet; 1997 May; 349(9061):1268. PubMed ID: 9142059
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.